Skin Prick Test Predictive Values for the Outcome of Cashew Challenges in Children.

Cashew allergy Food allergy Population Predictive value of tests Skin prick test Tree nut allergy

Journal

The journal of allergy and clinical immunology. In practice
ISSN: 2213-2201
Titre abrégé: J Allergy Clin Immunol Pract
Pays: United States
ID NLM: 101597220

Informations de publication

Date de publication:
01 2020
Historique:
received: 25 11 2018
revised: 10 05 2019
accepted: 29 05 2019
pubmed: 6 7 2019
medline: 15 5 2021
entrez: 6 7 2019
Statut: ppublish

Résumé

Cashew is a common cause of tree nut allergy in children. To date there have been few studies of diagnostic tests for cashew allergy, and positive predictive values (PPVs) for cashew as well as other tree nuts are largely extrapolated from studies of peanut allergy. How relevant these cutoffs are for cashew has not been formally explored. We aimed to establish skin prick test (SPT) wheal sizes that correlated to 95% PPV for a positive food challenge for cashew. We included all cashew oral food challenges (OFCs) conducted as part of the HealthNuts (n = 108; age, 4-6 years) and SchoolNuts (n = 37; age, 10-14 years) studies, both recruited from the community (population cohort). A second cohort of all cashew OFCs conducted at the Royal Children's Hospital (RCH) allergy center (n = 343) (2011-2016) and a private allergy clinic based at RCH (n = 43) was included via electronic medical record review (clinic cohort). The 95% PPV for cashew SPT was calculated for both cohorts. Among the population cohort (n = 145), 62% of cashew OFCs were positive compared with 20% of the clinic cohort (n = 386). The SPT cutoff for 95% PPV derived from the population cohort was 10 mm (95% confidence interval [CI], 7.5-12.0). For the clinic cohort, the 95% PPV was 14 mm (95% CI, 9.5-unknown). An SPT wheal size of 8 mm had a PPV of 89% (95% CI, 79-95) in the population cohort and 62% (95% CI, 45-78) in the clinic cohort. A higher SPT wheal size may be more appropriate than the commonly used 8 mm cutoff to guide clinical decisions around when to perform OFC for cashew.

Sections du résumé

BACKGROUND
Cashew is a common cause of tree nut allergy in children. To date there have been few studies of diagnostic tests for cashew allergy, and positive predictive values (PPVs) for cashew as well as other tree nuts are largely extrapolated from studies of peanut allergy. How relevant these cutoffs are for cashew has not been formally explored.
OBJECTIVE
We aimed to establish skin prick test (SPT) wheal sizes that correlated to 95% PPV for a positive food challenge for cashew.
METHODS
We included all cashew oral food challenges (OFCs) conducted as part of the HealthNuts (n = 108; age, 4-6 years) and SchoolNuts (n = 37; age, 10-14 years) studies, both recruited from the community (population cohort). A second cohort of all cashew OFCs conducted at the Royal Children's Hospital (RCH) allergy center (n = 343) (2011-2016) and a private allergy clinic based at RCH (n = 43) was included via electronic medical record review (clinic cohort). The 95% PPV for cashew SPT was calculated for both cohorts.
RESULTS
Among the population cohort (n = 145), 62% of cashew OFCs were positive compared with 20% of the clinic cohort (n = 386). The SPT cutoff for 95% PPV derived from the population cohort was 10 mm (95% confidence interval [CI], 7.5-12.0). For the clinic cohort, the 95% PPV was 14 mm (95% CI, 9.5-unknown). An SPT wheal size of 8 mm had a PPV of 89% (95% CI, 79-95) in the population cohort and 62% (95% CI, 45-78) in the clinic cohort.
CONCLUSION
A higher SPT wheal size may be more appropriate than the commonly used 8 mm cutoff to guide clinical decisions around when to perform OFC for cashew.

Identifiants

pubmed: 31276826
pii: S2213-2198(19)30590-2
doi: 10.1016/j.jaip.2019.05.057
pii:
doi:

Substances chimiques

Allergens 0
Immunoglobulin E 37341-29-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-148.e2

Investigateurs

Terence Dwyer (T)
Adrian Lowe (A)
Melissa Wake (M)
Colin Robertson (C)
Susan Sawyer (S)
George Patton (G)
Jo Douglass (J)
Peter Vuillermin (P)

Informations de copyright

Copyright © 2019 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Auteurs

Vicki McWilliam (V)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Melbourne, Australia; Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia; Melbourne Allergy Centre and Children's Specialists, Melbourne, Australia.

Rachel L Peters (RL)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Melbourne, Australia.

Katrina J Allen (KJ)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia.

Shyamali C Dharmage (SC)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, Australia.

Anne-Louise Ponsonby (AL)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Melbourne, Australia.

Mimi L K Tang (MLK)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Melbourne, Australia; Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia.

Joanne Smart (J)

Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia.

Kirsten Perrett (K)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of General Medicine, Royal Children's Hospital, Melbourne, Australia.

Dean Tey (D)

Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia; Melbourne Allergy Centre and Children's Specialists, Melbourne, Australia.

Marnie Robinson (M)

Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia; Melbourne Allergy Centre and Children's Specialists, Melbourne, Australia.

Mark Taranto (M)

Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia; Melbourne Allergy Centre and Children's Specialists, Melbourne, Australia.

Jennifer J Koplin (JJ)

Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Melbourne, Australia; Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Melbourne, Australia; Department of General Medicine, Royal Children's Hospital, Melbourne, Australia. Electronic address: jennifer.koplin@mcri.edu.au.

Lyle C Gurrin (LC)

Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, The University of Melbourne, Melbourne, Australia; Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH